Skip to main content

Table 2 Overnight sleep monitoring results stratified by the interaction term between OSA and homocysteine

From: Prognostic implications of obstructive sleep apnea in patients with acute coronary syndrome stratified by homocysteine level: a prospective cohort study

Variables

Homocysteine ≤ 15 μmol/L

P

Homocysteine > 15 μmol/L

P

P*

OSA (n = 521)

Non-OSA (n = 467)

OSA (n = 298)

Non-OSA (n = 267)

AHI, events/h

28.8 (20.7, 41.6)

7.7 (3.7, 10.6)

 < 0.001

29.4 (21.4, 43.0)

7.8 (5.0, 11.0)

 < 0.001

0.522

ODI, events/h

27.1 (20.0, 39.0)

8.6 (4.6, 12.0)

 < 0.001

27.9 (21.2, 40.5)

8.8 (5.4, 11.9)

 < 0.001

0.457

T90, %

6.0 (2.0, 16.0)

0.6 (0.0, 3.0)

 < 0.001

6.4 (2.0, 14.0)

0.9 (0.1, 3.0)

 < 0.001

0.640

Minimum SaO2, %

83 (77, 86)

87 (84, 90)

 < 0.001

82 (77, 86)

87 (84, 89)

 < 0.001

0.133

Mean SaO2, %

93 (92, 94)

95 (93, 95)

 < 0.001

93 (92, 94)

94 (93, 95)

 < 0.001

0.077

ESS scoring

8 (4, 12)

6 (3, 10)

0.001

8 (5, 12)

6 (3, 10)

0.002

0.677

  1. AHI apnea and hypopnea index, ESS the Epworth Sleepiness Scale, ODI oxygen desaturation index, T90 percentage of time with SaO2 < 90%, SaO2 oxyhemoglobin saturation